Adient (NYSE:ADNT) Given Consensus Rating of “Hold” by Brokerages

Shares of Adient (NYSE:ADNT) have been assigned an average recommendation of “Hold” from the eleven brokerages that are currently covering the company, Marketbeat.com reports. Two equities research analysts have rated the stock with a sell recommendation, six have issued a hold recommendation and three have given a buy recommendation to the company. The average twelve-month price objective among analysts that have covered the stock in the last year is $24.1875.

A number of equities analysts have commented on the company. JPMorgan Chase & Co. reduced their price objective on Adient from $26.00 to $24.00 and set a “neutral” rating on the stock in a research note on Thursday, November 6th. Wells Fargo & Company raised their price objective on shares of Adient from $28.00 to $29.00 and gave the company an “overweight” rating in a research report on Monday, January 12th. UBS Group set a $30.00 target price on shares of Adient and gave the stock a “buy” rating in a research report on Wednesday. Barclays lowered their price target on shares of Adient from $27.00 to $24.00 and set an “equal weight” rating for the company in a report on Friday, November 7th. Finally, Weiss Ratings reaffirmed a “sell (d)” rating on shares of Adient in a report on Wednesday, October 8th.

Adient Stock Performance

NYSE:ADNT opened at $22.01 on Friday. The company has a market capitalization of $1.74 billion, a P/E ratio of -6.59, a price-to-earnings-growth ratio of 0.73 and a beta of 1.61. Adient has a twelve month low of $10.04 and a twelve month high of $26.16. The company has a current ratio of 1.12, a quick ratio of 0.93 and a debt-to-equity ratio of 1.16. The firm has a 50-day moving average price of $19.64 and a two-hundred day moving average price of $22.06.

Adient (NYSE:ADNT) last posted its quarterly earnings data on Wednesday, November 5th. The company reported $0.52 earnings per share for the quarter, missing the consensus estimate of $0.55 by ($0.03). The firm had revenue of $3.68 billion for the quarter, compared to analyst estimates of $3.58 billion. Adient had a positive return on equity of 7.81% and a negative net margin of 1.93%.The business’s quarterly revenue was up 3.5% on a year-over-year basis. During the same period in the previous year, the business posted $0.68 EPS. As a group, research analysts expect that Adient will post 1.76 earnings per share for the current fiscal year.

Insider Buying and Selling

In other Adient news, EVP Michel Pierre Rose Berthelin sold 2,500 shares of the business’s stock in a transaction dated Wednesday, November 26th. The stock was sold at an average price of $19.71, for a total transaction of $49,275.00. Following the completion of the sale, the executive vice president directly owned 116,425 shares of the company’s stock, valued at approximately $2,294,736.75. The trade was a 2.10% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. 0.72% of the stock is currently owned by insiders.

Institutional Investors Weigh In On Adient

Institutional investors and hedge funds have recently modified their holdings of the business. Vanguard Group Inc. raised its holdings in shares of Adient by 3.9% in the 3rd quarter. Vanguard Group Inc. now owns 4,475,944 shares of the company’s stock worth $107,781,000 after purchasing an additional 166,319 shares during the period. Dimensional Fund Advisors LP increased its position in Adient by 8.5% in the third quarter. Dimensional Fund Advisors LP now owns 4,215,764 shares of the company’s stock worth $101,517,000 after buying an additional 328,555 shares during the last quarter. Pzena Investment Management LLC raised its stake in shares of Adient by 7.0% in the second quarter. Pzena Investment Management LLC now owns 4,174,493 shares of the company’s stock valued at $81,236,000 after buying an additional 272,920 shares during the period. Arrowstreet Capital Limited Partnership lifted its position in shares of Adient by 61.3% during the 3rd quarter. Arrowstreet Capital Limited Partnership now owns 1,890,233 shares of the company’s stock valued at $45,517,000 after buying an additional 718,538 shares during the last quarter. Finally, Letko Brosseau & Associates Inc. bought a new position in shares of Adient during the 2nd quarter worth $28,839,000. 92.44% of the stock is owned by institutional investors.

Adient Company Profile

Adient plc (NYSE: ADNT) is a leading global supplier of automotive seating and interior components. Established in 2016 through a spin-off from Johnson Controls, the company designs, engineers and manufactures complete seat assemblies, seat structures, mechanisms, foams, textiles, trim and electronics. Adient’s product portfolio spans a wide range of seating solutions, from entry-level designs to luxury and high-performance seats, and extends to interior modules such as door panels and center consoles.

Serving major original equipment manufacturers (OEMs) around the world, Adient works closely with automakers to develop lightweight, comfortable and safety-oriented seating systems.